Acute lung injury induced by lipopolysaccharide is independent of complement activation

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7664-7672

  Rittirsch, Daniel ^a   Flierl, Michael A ^a   Day, Danielle E ^a   Nadeau, Brian A ^a   McGuire, Stephanie R ^a   Hoesel, Laszlo M ^a   Ipaktchi, Kyros ^a   Zetoune, Firas S ^a   Sarma, J Vidya ^a   Leng, Lin ^d   Huber Lang, Markus S ^c   Neff, Thomas A ^b   Bucala, Richard ^d   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; HIGH MOBILITY GROUP B1 PROTEIN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR RECEPTOR; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; AUTACOID; COMPLEMENT;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOPATHOGENESIS; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; LUNG; MALE; METABOLISM; MOUSE MUTANT;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; INFLAMMATION MEDIATORS; LEUKOTRIENE B4; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 47249119631     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7664     Document Type: Article

References (55)

1. Johnson, K. J., and P. A. Ward. 1974. Acute immunologic pulmonary alveolitis. J. Clin. Invest. 54: 349-357.
2. Flierl, M. A., D. Rittirsch, L. M. Hoesel, H. Gao, M. Huber-Lang, and P. A. Ward. 2006. Acute lung injury: a challenging transfer from bench to bedside. Med. Hypothesis Res. 3: 727-738.
3. Kabir, K., J. P. Gelinas, M. Chen, D. Chen, D. Zhang, X. Luo, J. H. Yang, D. Carter, and R. Rabinovici. 2002. Characterization of a murine model of en-dotoxin-induced acute lung injury. Shock 17; 300-303.
4. Ward, P. A. 1996. Rous-Whipple Award lecture: role of complement in lung inflammatory injury. Am. J. Pathol. 149: 1081-1086.
5. Hammerschmidt, D. E., L. J. Weaver, L. D. Hudson, P. R. Craddock, and H. S. Jacob. 1980. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome: pathophysiological relevance and possible prognostic value. Lancet 1: 947-949.
6. Solomkin, J. S., L. A. Cotta, P. S. Satoh, J. M. Hurst, and R. D. Nelson. 1985. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man. Surgery 97: 668-678.
7. Mulligan, M. S., E. Schmid, B. Beck-Schimmer, G. O. Till, H. P. Friedl, R. B. Brauer, T. E. Hugli, M. Miyasaka, R. L. Warner, K. J. Johnson, and P. A. Ward. 1996. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98: 503-512.
8. Warren, J. S., K. R. Yabroff, D. G. Remick, S. L. Kunkel, S. W. Chensue, R. G. Kunkel, K. J. Johnson, and P. A. Ward. 1989. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84: 1873-1882.
9. Shanley, T. P., J. L. Foreback, D. G. Remick, T. R. Ulich, S. L. Kunkel, and P. A. Ward. 1997. Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. Am. J. Pathol. 151: 193-203.
10. Speyer, C. L., H. Gao, N. J. Rancilio, T. A. Neff, G. B. Huffnagle, J. V. Sarma, and P. A. Ward. 2004. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am. J. Pathol. 165: 2187-2196.
11. Oishi, K., N. L. Koles, G. Guelde, and M. Pollack. 1992. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. J. Infect. Dis. 165: 34-45.
12. Mintz, C. S., D. R. Schultz, P. I. Arnold, and W. Johnson. 1992. Legionella pneumophila lipopolysaccharide activates the classical complement pathway. Infect. Immun. 60: 2769-2776.
13. Vukajlovich, S. W., J. Hoffman, and D. C. Morrison. 1987. Activation of human serum complement by bacterial Iipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways. Mol. Immunol. 24: 319-331.
14. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173: 89-97.
15. Saito, T., T. Yamamoto, T. Kazawa, H. Gejyo, and M. Naito. 2005. Expression of Toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse. Cell Tissue Res. 321: 75-88.
16. Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K. J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165: 2950-2954.
17. Reutershan, J., A. Basit, E. V. Galkina, and K. Ley. 2005. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am. J. Physiol. 289: L807-L815.
18. Circolo, A., G. Gamier, W. Fukuda, X. Wang, T. Hidvegi, A. J. Szalai, D. E. Briles, J. E. Volanakis, R. A. Wetsel, and H. R. Colten. 1999. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42: 135-149.
19. Wheat, W. H., R. Wetsel, A. Falus, B. F. Tack, and R. C. Strunk. 1987. The fifth component of complement (C5) in the mouse: analysis of the molecular basis for deficiency. J. Exp. Med. 165: 1442-1447.
20. Neff, T. A., R. F. Guo, S. B. Neff, J. V. Sarma, C. L. Speyer, H. Gao, K. D. Bemacki, M. Huber-Lang, S. McGuire, L. M. Hoesel, et al. 2005. Relationship of acute lung inflammatory injury to Fas/FasL system. Am. J. Pathol. 166: 685-694.
21. Hoesel, L. M., T. A. Neff, S. B. Neff, J. G. Younger, E. W. Olle, H. Gao, M. J. Pianko, K. D. Bernacki, J. V. Sarma, and P. A. Ward. 2005. Harmful and protective roles of neutrophils in sepsis. Shock 24: 40-47.
22. Huber-Lang, M. S., J. V. Sarma, S. R. McGuire, K. T. Lu, R. F. Guo, V. A. Padgaonkar, E. M. Younkin, I. J. Laudes, N. C. Riedemann, J. G. Younger, and P. A. Ward. 2001. Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J. 15: 568-570.
23. Noiri, E., T. Yokomizo, A. Nakao, T. Izumi, T. Fujita, S. Kimura, and T. Shimizu. 2000. An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury. Proc. Natl. Acad. Sci. USA 97: 823-828.
24. Huber-Lang, M, J. V. Sarma, F. S. Zetoune, D. Rittirsch, T. A. Neff, S. R. McGuire, J. D. Lambris, R. L. Warner, M. A. Flierl, L. M. Hoesel, et al. 2006. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12: 682-687.
25. Kelley, J. 1990. Cytokines of the lung. Am. Rev. Respir. Dis. 141: 765-788.
26. Reutershan, J., M. A. Morris, T. L. Burcin, D. F. Smith, D. Chang, M. S. Saprito, and K. Ley. 2006. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J. Clin. Invest. 116: 695-702.
27. Donnelly, S. C, C. Haslett, P. T. Reid, I. S. Grant, W. A: Wallace, C. N. Metz, L. J. Bruce, and R. Bucala. 1997. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. 3: 320-323.
28. Miyahara, N., S. Miyahara, K. Takeda, and E. W. Gelfand. 2006. Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation. Allergol. Int. 55: 91-97.
29. Martin, T. R., G. D. Rubenfeld, J. T. Ruzinski, R. B. Goodman, K. P. Steinberg, D. J. Leturcq, A. M. Moriarty, G. Raghu, R. P. Baughman, and L. D. Hudson. 1997. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155: 937-944.
30. Burrell, R., R. C. Lantz, and D. E. Hinton. 1988. Mediators of pulmonary injury induced by inhalation of bacterial endotoxin. Am. Rev. Respir. Dis. 137: 100-105.
31. Bolger, M. S., D. S. Ross, H. Jiang, M. M. Frank, A. J. Ghio, D. A. Schwartz, and J. R. Wright. 2007. Complement levels and activity in the normal and LPS-injured lung. Am. J. Physiol. 292: L748-L759.
32. Rabinovici, R., C. G. Yeh, L. M. Hillegass, D. E. Griswold, M. J. DiMartino, J. Vernick, K. L. Fong, and G. Feuerstein. 1992. Role of complement in endotoxin/platelet-activating factor-induced lung injury. J. Immunol. 149: 1744-1750.
33. Pittet, J. F., R. C. Mackersie, T. R. Martin, and M. A. Matthay. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155: 1187-1205.
34. Parsons, P. E., A. A. Fowler, T. M. Hyers, and P. M. Henson. 1985. Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132: 490-493.
35. Hetland, G., E. Johnson, and U. Aasebo.-1986. Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro. Scand. J. Immunol. 24: 603-608.
36. Strunk, R. C., D. M. Eidlen, and R. J. Mason. 1988. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J. Clin, Invest. 81: 1419-1426.
37. Watford, W. T., J. R. Wright, C. G. Hester, H. Jiang, and M. M. Frank. 2001. Surfactant protein A regulates complement activation. J. Immunol. 167: 6593-6600.
38. Watford, W. T., A. J. Ghio, and J. R. Wright. 2000. Complement-mediated host defense in the lung. Am. J. Physiol. 279: L790-L798.
39. Seeger, W., A. Gunther, H. D. Walmrath, F. Grimminger, and H. G. Lasch. 1993. Alveolar surfactant and adult respiratory distress syndrome: pathogenetic role and therapeutic prospects. Clin. Invest. 71: 177-190.
40. Carvalho, A. C, S. DeMarinis, C. F. Scott, L. D. Silver, A. H. Schmaier, and R. W. Colman. 1988. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. J. Lab. Clin. Med. 112: 270-277.
41. Li, S., S. A. Boackle, V. M. Holers, J. D. Lambris, and C. M. Blatteis. 2005. Complement component C5a is integral to the febrile response of mice to lipopolysaccharide. Neuroimmunomodulation 12: 67-80.
42. Barton, P. A., and J. S. Warren. 1993. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect. Int-mun. 61: 1474-1481.
43. Fischer, M. B., A. P. Prodeus, A. Nicholson-Weller, M. Ma, J. Murrow, R. R. Reid, H. B. Warren, A. L. Lage, F. D. Moore, Jr., F. S. Rosen, and M. C. Carroll. 1997. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by Cl inhibitor replacement. J. Immunol. 159: 976-982.
44. Nishihira, J. 2000. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J. Interferon Cytokine Res. 20: 751-762.
45. Leng, L., and R. Bncala 2005. Macrophage migration inhibitory factor. Crit. Care Med. 33: S475-S477.
46. Kudrin, A., M. Scott, S. Martin, C. W. Chung, R. Donn, A. McMaster, S. Ellison, D. Ray, K. Ray, and M. Binks. 2006. Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J. Biol. Chem. 281: 29641-29651.
47. Makita, H., M. Nishimura, K. Miyamoto, T. Nakano, Y. Tanino, J. Hirokawa, J. Nishihira, and Y. Kawakami. 1998. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am. J. Respir. Crit. Care Med. 158: 573-579.
48. Roger, T., J. David, M. P. Glauser, and T. Calandra. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414: 920-924.
49. Rae, S. A., and M. J. Smith. 1981. The stimulation of lysosomal enzyme secretion from human polymorphonuclear leucocytes by leukotriene B4. J. Pharm. Pharmacol. 33: 616-617.
50. Lamblin, C, P. Gosset, I. Tillie-Leblond, F. Saulnier, C. H. Marquette, B. Wallaert, and A. B. Tonnel. 1998. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am. J. Respir. Crit. Care Med. 157: 394-402.
51. Suda, N., I. Morita, T. Kuroda, and S. Murota. 1992. Priming effects of leukotriene B4 on endothelial cell injury induced by TPA-activated leukocytes. Inflammation 16: 307-314.
52. Sibelius, U., K. Hattar, S. Hoffmann, K. Mayer, U. Grandel, A. Schenkel, W. Seeger, and F. Grimminger. 2002. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10. Crit. Care Med. 30: 2306-2312.
53. Martin, T. R., B. P. Pistorese, E. Y. Chi, R. B. Goodman, and M. A. Matthay. 1989. Effects of leukotriene B4 in the human lung: recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J. Clin. Invest. 84: 1609-1619.
54. 4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade. J. Immunol. 170: 6273-6279.
55. Young, R. E., M. B. Voisin, S. Wang, J. Dangerfield, and S. Nourshargh. 2007. Role of neutrophil elastase in LTB4-induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice. Br. J. Pharmacol. 151: 628-637.